MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

This publication has 118 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin
  Neuropharmacology, 1989
• Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
• Inhibition of aromatic L-aminoacid decarboxylase in clonal pheochromocytoma PC12h cells by N-methyl-4-phenylpyridinium ion (MPP+)
  Biochemical and Biophysical Research Communications, 1988
• MPTP induced dopaminergic neurotoxicity—a useful model in the study of parkinson's disease?
  Neurochemistry International, 1987
• The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals
  Biochemical and Biophysical Research Communications, 1985
• Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Biochemical and Biophysical Research Communications, 1985
• IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
  Life Sciences, 1985
• II. Selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity?
  Life Sciences, 1985
• Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP
  Biochemical and Biophysical Research Communications, 1984